Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Gastroenterology. 2015 Oct 21;150(2):419–429. doi: 10.1053/j.gastro.2015.10.013

Figure 2.

Figure 2

Model adjusted estimates of SVR12 among patients treated with simeprevir plus sofosbuvir with or without ribavirin.

Population: patients which completed a full course of treatment or prematurely discontinued treatment for virological reasons.

Adjusted SVR12 estimates derived from a logistic regression model which simultaneously adjusted for regimen, subtype (1a versus 1b), cirrhosis status, previous treatment experience, prior PI failure, history of prior decompensation, sex, age, and baseline chemistry measures of albumin, aspartate aminotransferase, creatinine, HCV RNA, HGB, and total bilirubin.